Oracle (ORCL) Stock Slips 4.5% on $20 Billion OpenAI Revenue Gap

Oracle Leads a Broad AI Stock Selloff

Oracle's stock led a broad selloff across AI-linked equities on Thursday, October 8, dropping more than 5% during the session after a Financial Times report cast fresh doubt on how much money OpenAI is actually earning. The report put OpenAI's annualized revenue, a projection that stretches one month's sales across a full year, near $50 billion at the end of September. That sits well below the $70 billion figure reported earlier, leaving a $20 billion gap that traders treated as a warning about the economics behind the AI buildout. The shortfall does not mean OpenAI lost $20 billion in actual sales. It largely reflects differences in how revenue is calculated between the two readings, and OpenAI's revenue has reportedly grown more than 70% since July. Markets sold first and asked questions later. Broadcom (AVGO) fell nearly 4%, Nvidia (NVDA) dropped more than 2% and Microsoft (MSFT) lost over 1% in Thursday trading. Oracle has more reason than most to react. The company supplies a large share of the computing power behind ChatGPT, and its stock has re-rated on the promise of AI cloud demand, so any question about OpenAI's finances lands directly on Oracle's valuation. COINOTAG data shows Oracle (ORCL) last trading at $136.72, down 4.51% over 24 hours, after touching $134.90 at the low and $144.26 at the high. For a company valued on future cloud contracts rather than current cash flow, a one-third markdown in its largest customer's revenue run rate was enough to force a repricing across the AI supply chain.

A $300 Billion Contract Ties Oracle to OpenAI

A single agreement explains the sensitivity. In September 2025, Oracle and OpenAI signed a $300 billion cloud computing deal that runs five years, a contract equal to roughly 45% of Oracle's $664 billion backlog of contracted future revenue. The backlog is the total value of contracts already signed but not yet billed, and Oracle has to build the data centers before it collects most of that money. Its latest quarterly results showed $28.5 billion in capital expenditure and $5.4 billion in negative free cash flow, a profile that leaves the company spending heavily now against income it will book over years. Timing is the core risk. The Wall Street Journal reported Thursday that Oracle, Broadcom and SpaceX are seeking large debt deals to pay for AI chips. Oracle's own position is that AI cloud demand “continues to grow faster than supply,” and the revenue report changes nothing about the volume of compute OpenAI has committed to buy. That concentration is what separates Oracle from its peers: nearly half of its contracted future revenue rests on one customer's ability to pay. The exposure, however, extends well beyond one stock. CoreWeave (CRWV) holds announced cloud contracts with OpenAI worth as much as $22.4 billion. Broadcom is developing custom AI chips with the company and is reportedly arranging more than $50 billion in financing. AMD carries a six-gigawatt chip agreement, while Nvidia holds a 10-gigawatt infrastructure partnership. SoftBank (9984.T) faces exposure through its multibillion-dollar investment in the ChatGPT developer. Each of these names would come under fresh pressure if OpenAI's growth disappoints, and the damage in each case depends on how much future business investors have already priced in.

The technical picture shows how thin the cushion now is. COINOTAG's support and resistance scoring places the strongest floor for Oracle at $136.05, rated 71 out of 100 and reinforced by a Fibonacci retracement level, while the heaviest resistance sits at $148.56 with a 100 out of 100 score. The daily RSI reads 40.7 and the daily trend stays sideways. In the stock perpetual market, open interest stands near $30.6 million and the funding rate at 0.0061% per interval, so the drop came without crowded leverage behind it. On the pre-IPO OpenAI instrument, the last price read $1,644.28, down 3.77% over 24 hours. A daily close below $136.05 would deepen Oracle's slide; a recovery through $148.56 would put the pre-report range back in play.